Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286

Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286

Submitted by admin on March 17, 2022 - 10:16am
Source: 
Pharmaceutical Business Review
News Tags: 
Clovis Oncology
Evergreen Theragnostics
radiolabeling
Headline: 
Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286
snippet: 

Clovis Oncology and Evergreen Theragnostics have initiated a development, manufacturing, and services agreement for actinium-225-labeled-FAP-2286 (225Ac-FAP-2286).

Do Not Allow Advertisers to Use My Personal information